29th January 2025
7th January 2025
Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)
1st October 2024
AstronauTx Appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team
30th September 2024
Aktis Oncology Announces $175 Million Oversubscribed Series B Financing
9th July 2024
Aktis Oncology Appoints Akos Czibere, MD, PhD, Chief Medical Officer
23rd May 2024
Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies
7th May 2024
Ivan Cheung, CEO of NextPoint Therapeutics, Named to TIME Magazine’s Top 100 Most Influential People in Global Health
2nd May 2024
Reunion Neuroscience Inc. Announces $103 Million Series A Financing
27th February 2024
ReNAgade Therapeutics Appoints Joe Bolen, Ph.D., Chief Science Innovation Officer
23rd February 2024